Raymond James Financial’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.28M Buy
49,953
+1,952
+4% +$153K ﹤0.01% 2874
2026
Q2
$3.3M Buy
48,001
+2,567
+6% +$174K ﹤0.01% 3089
2026
Q1
$3.41M Buy
45,434
+9,073
+25% +$743K ﹤0.01% 2914
2025
Q4
$2.84M Buy
36,361
+4,418
+14% +$359K ﹤0.01% 2984
2025
Q3
$2.71M Buy
31,943
+3,925
+14% +$314K ﹤0.01% 2930
2025
Q2
$2.19M Buy
28,018
+3,308
+13% +$244K ﹤0.01% 3011
2025
Q1
$1.79M Sell
24,710
-45,631
-65% -$3.83M ﹤0.01% 3073
2024
Q4
$6.24M Buy
+70,341
New +$6.27M ﹤0.01% 2184

Other funds holding USPH

Raymond James Financial's USPH Position: Q3 2026 in Review

Raymond James Financial increased its US Physical Therapy (USPH) stake by 4.1% in Q3 2026, buying an estimated $153K and bringing the position to 49,953 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

Raymond James Financial first reported a position in USPH in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.24M in Q4 2024. 235 funds tracked by Wall St. Rank hold USPH as of Q3 2026.

  • Raymond James Financial held 49,953 shares of US Physical Therapy worth $4.28M as of Q3 2026.
  • Raymond James Financial bought 1,952 US Physical Therapy shares in Q3 2026, an estimated $153K.
  • US Physical Therapy made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2874 holding.
  • Raymond James Financial first reported a position in US Physical Therapy in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's US Physical Therapy position peaked at $6.24M in Q4 2024.
  • 235 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.